** Shares of SomnoMed Ltd SOM.AX fall 12.3% to A$0.465, their lowest levels since January 20
** The medical device maker plans to absorb the costs associated with the tariff changes in the immediate term and reiterates FY25 outlook for revenue and EBITDA
** Co imports its products to the U.S. and manufactures them primarily in the Philippines
** Stock posts biggest percentage drop since December 16
** Stock sees busiest session since early February
** Stock up 1.1% YTD, including moves in current session
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。